Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 108Lymphoma, Large B-Cell, Diffuse 97Lymphoma 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Lymphoma, Non-Hodgkin 37Lymphoma, Follicular 37Burkitt Lymphoma 36Leukemia 31Multiple Myeloma 29Lymphoma, Mantle-Cell 26Hodgkin Disease 25Lymphoma, T-Cell, Peripheral 20Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Large-Cell, Anaplastic 15Lymphoma, B-Cell, Marginal Zone 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Neoplasm Metastasis 13Lymphoma, B-Cell 13Leukemia, Lymphocytic, Chronic, B-Cell 12Recurrence 11Neoplasms, Plasma Cell 11Immunoblastic Lymphadenopathy 11Lymphoma, T-Cell 8Dendritic Cell Sarcoma, Interdigitating 8Blast Crisis 8Neoplasms 7Enteropathy-Associated T-Cell Lymphoma 7Waldenstrom Macroglobulinemia 5Primary Myelofibrosis 5Myasthenia Gravis 5

Interventions

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Cyclophosphamide 3fludarabine 1Vincristine 1Prednisone 1Etoposide 1Doxorubicin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Experimental × Prednisone × Clear all
NCT03617432 2018-09-04

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

Peking University

Phase 2 Unknown
114 enrolled

Neoplasms, Experimental

Data powered by HemOnc (CC BY 4.0) Colophon âš¡